A Phase 3 Study of Ensitrelvir in Japanese Participants Aged 6-11 Years with SARS-CoV-2 Infection
Nakano et al., Journal of the Pediatric Infectious Diseases Society, doi:10.1093/jpids/piag071
https://c19early.org/nakano.html